Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation

Journal of Molecular Biology

Volumn 290, Issue 5, 1999, Pages 929-941

  Isel, Catherine ^a   Karn, Jonathan ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

RNA polymerase phosphorylation; Tat associated kinase; Transcription elongation; Transcription initiation

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN KINASE; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033618442     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2933     Document Type: Article

References (47)

1. Bieniasz P. D., Grdina T. A., Bogerd H. P., Cullen B. R. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:1998;7056-7065.
2. Chen D., Zhou Q. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase. Mol. Cell Biol. 19:1999;2863-2871.
3. Chen D., Fong Y., Zhou Q. Specific interaction of Tat with the human but not rodent pTEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc. Natl Acad. Sci. USA. 96:1999;2728-2733.
4. Churcher M., Lamont C., Hamy F., Dingwall C., Green S. M., Lowe A. D., Butler P. J. G., Gait M. J., Karn J. High affinity binding of TAR RNA by the human immunodeficiency virus Tat protein requires amino acid residues flanking the basic domain and base-pairs in the RNA stem. J. Mol. Biol. 230:1993;90-110.
5. Churcher M. J., Lowe A. D., Gait M. J., Karn J. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription. Proc. Natl Acad. Sci. USA. 92:1995;2408-2412.
6. Cujec T. P., Okamoto H., Fujinaga K., Meyer J., Chamberlin H., Morgan D. O., Peterlin B. M. The HIV trans-activator Tat binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:1997;2645-2657.
7. Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skinner M. A., Valerio R. Human immunodeficiency virus 1 Tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc. Natl Acad. Sci. USA. 86:1989;6925-6929.
8. Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skinner M. A. HIV-1 Tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9:1990;4145-4153.
9. Dubois M.-F., Vincent M., Vigneron M., Adamczewski J., Egly J.-M., Bensaude O. Heat-shock inactivation of the TFIIH-associated kinase and change in the phosphorylation sites on the C-terminal domain of RNA polymerase II. Nucl. Acids Res. 25:1997;694-700.
10. Fujinaga K., Taube R., Wimmer J., Cujec T. P., Peterlin B. M. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl Acad. Sci. USA. 96:1999;1285-1290.
11. Garber M. E., Wei P., KewelRamani V. N., Mayall T. P., Herrmann C. H., Rice A. P., Littman D. R., Jones K. A. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:1998;3512-3527.
12. García-Martínez L. F., Mavankal G., Neveu J. M., Lane W. S., Ivanov D., Gaynor R. B. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:1997;2836-2850.
13. Gold M. O., Yang X., Herrmann C. H., Rice A. P. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat trans-activation in vivo. J. Virol. 72:1998;4448-4453.
14. Graeble M. A., Churcher M. J., Lowe A. D., Gait M. J., Karn J. Human immunodeficiency virus type 1 trans-activator protein Tat, stimulates transcriptional read-through of distal terminator sequences in vitro. Proc. Natl Acad. Sci. USA. 90:1993;6184-6188.
15. Herrmann C. H., Rice A. P. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology. 197:1993;601-608.
16. Herrmann C. H., Rice A. P. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1995;1612-1620.
17. Ivanov D., Kwak Y. T., Nee E., Guo J., Garcia-Martinez L. F., Gaynor R. B. Cyclin T domains involved in complex formation with Tat and TAR RNA are critical for Tat-activation. J. Mol. Biol. 288:1999;41-56.
18. Jones K. A. Taking a new TAK on Tat trans-activation. Genes Dev. 11:1997;2593-2599.
19. Kato H., Sumimoto H., Pognonec P., Chen C.-H., Rosen C. A., Roeder R. G. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:1992;655-666.
20. Keen N. J., Gait M. J., Karn J. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl Acad. Sci. USA. 93:1996;2505-2510.
21. Keen N. J., Churcher M. J., Karn J. Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J. 16:1997;5260-5272.
22. Kelly W. G., Dahmus M. E., Hart G. W. RNA polymerase II is a glycoprotein: modification of the COOH-terminal domain by O-GlcNAc. J. Biol. Chem. 268:1993;10416-10424.
23. Kwak Y. T., Ivanov D., Guo J., Nee E., Gaynor R. B. Role of the human and murine cyclin T proteins in regulating HIV-1 Tat-activation. J. Mol. Biol. 288:1999;57-69.
24. Laspia M. F., Wendel P., Mathews M. B. HIV-1 Tat overcomes inefficient transcriptional elongation in vitro. J. Mol. Biol. 232:1993;732-746.
25. Laybourn P. J., Dahmus M. E. Phosphorylation of RNA polymerase IIA occurs subsequent to interaction with the promoter and before the initiation of transcription. J. Biol. Chem. 265:1990;13165-13173.
26. Li X.-Y., Green M. R. The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor. Genes Dev. 12:1998;2992-2996.
27. Mancebo H. S. Y., Lee G., Flygare J., Tomassini J., Luu P., Zhu Y., Peng J., Blau C., Hazuda D., Price D., Flores O. p-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:1997;2633-2644.
28. Marciniak R. A., Sharp P. A. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:1991;4189-4196.
29. Marshall N. F., Price D. H. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell Biol. 12:1992;2078-2090.
30. Marshall N. F., Peng J., Xie Z., Price D. H. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271:1996;27176-27183.
31. Mitsui A., Sharp P. A. Ubiquitination of RNA polymerase II large subunit signaled by phosphorylation of carboxyl-terminal domain. Proc. Natl Acad. Sci. USA. 96:1999;6054-6059.
32. O'Brien T., Hardin S., Greenleaf A., Lis J. T. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature. 370:1994;75-77.
33. Parada C. A., Roeder R. G. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature. 384:1996;375-378.
34. Peng J., Marshall N. F., Price D. H. Identification of a cyclin subunit required for the function of Drosophila p-TEFb. J. Biol. Chem. 273:1998;13855-13860.
35. Ping Y.-H., Rana T. M. Tat-associated kinase (pTEF-b): a component of transcription preinitiation and elongation complexes. J. Biol. Chem. 274:1999;7399-7404.
36. Rittner K., Churcher M. J., Gait M. J., Karn J. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. J. Mol. Biol. 248:1995;562-580.
37. Thompson N. E., Burgess R. R. Immunoaffinity purification of RNA polymerase II and transcription factors using polyol-responsive monoclonal antibodies. Methods Enzymol. 274:1996;513-526.
38. Thompson N. E., Aronson D. B., Burgess R. R. Purification of eukaryotic RNA polymerase II by immunoaffinity chromatography: Elution of active enzyme with protein stabilizing agents from a polyol-responsive monoclonal antibody. J. Biol. Chem. 265:1990;7069-7077.
39. Wada T., Takagai T., Yamaguchi Y., Watanabe D., Handa H. Evidence that pTEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17:1998;7395-7403.
40. Weeks K. M., Crothers D. M. RNA recognition by Tat-derived peptides: Interaction in the major groove? Cell. 66:1991;577-588.
41. Wei P., Garber M. E., Fang S.-M., Fischer W. H., Jones K. A. A novel cdk9-associated c-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop specific binding to TAR RNA. Cell. 92:1998;451-462.
42. West M. J., Karn J. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer. EMBO J. 18:1999;1378-1386.
43. Wright S., Luccarini C. Effect of the position of TAR on transcriptional activation by HIV-1 Tat in vivo. J. Mol. Biol. 263:1996;1-7.
44. Wu-Baer F., Lane W. S., Gaynor R. B. Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation. J. Mol. Biol. 277:1998;179-197.
45. Yankulov K., Yamashita K., Roy R., Egly J.-M., Bentley D. L. The transcriptional elongation inhibitor 5,6-dichloro-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J. Biol. Chem. 270:1995;23922-23925.
46. Zhou Q., Chen D., Pierstorff E., Luo K. Transcription elongation factor p-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17:1998;3681-3691.
47. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M. B., Price D. H. Transcription elongation factor p-TEFb is required for HIV-1 Tat trans-activation in vitro. Genes Dev. 11:1997;2622-2632.